242
Amneal Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
65.1
FY23:
346
FY24:
295
FY25:
340
Change from FY21 to FY25
millions USD
FY21:
−194
FY22:
−174
FY23:
−69.2
FY24:
−63.0
FY25:
−112
Change from FY21 to FY25
millions USD
FY21:
−138
FY22:
−107
FY23:
−213
FY24:
−212
FY25:
−31.5
millions USD
FY21:
−90.4
FY22:
−222
FY23:
63.9
FY24:
19.3
FY25:
195
(positive)
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
18.7
FY23:
302
FY24:
243
FY25:
270
All amounts in millions USD